Vivos (RDGL) EBT Margin Growth (1y) (2011 - 2025)
Powered by 
Analysis
Vivos (RDGL) EBT Margin Growth (1y) (2011 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | -719.00 |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 236.00 |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 295.00 |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 687.00 |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 88.00 |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 374.00 |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -938.00 |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 343.00 |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 165.00 |
| 10 | Vivos | 23.21 Mn | 23.21 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 1.61 Mn |
| Sep 30, 2025 | -1.05 Mn |
| Jun 30, 2025 | -57,410.00 |
| Mar 31, 2025 | 929,139.00 |
| Sep 30, 2024 | -696,683.00 |
| Jun 30, 2024 | 1.02 Mn |
| Mar 31, 2024 | -827,334.00 |
| Sep 30, 2023 | -527,589.00 |
| Jun 30, 2023 | -638,465.00 |
| Mar 31, 2023 | 124,525.00 |
| Sep 30, 2022 | -291,129.00 |
| Sep 30, 2021 | 58,577.00 |
| Sep 30, 2020 | 643,014.00 |
| Mar 31, 2018 | 515,505.00 |
| Mar 31, 2017 | 13.29 Mn |
| Sep 30, 2016 | 1.71 Mn |
| Mar 31, 2016 | -15.63 Mn |
| Mar 31, 2015 | 2.08 Mn |
| Mar 31, 2014 | -526,766.00 |
| Sep 30, 2013 | 279,663.00 |